Fibrous dysplasia of bone associated with soft-tissue myxomas as well as an intra-osseous myxoma in a woman with Mazabraud's syndrome: a case report
© van der Wal et al; licensee BioMed Central Ltd. 2011
Received: 25 May 2010
Accepted: 27 June 2011
Published: 27 June 2011
Mazabraud's syndrome is a rare but well-described disorder characterized by fibrous dysplasia in single or multiple bones associated with one or more soft-tissue myxomas. In this report, we describe what is, to the best of our knowledge, the first case involving an intra-osseous myxoma. This finding supports, and could provide new insight into, the pathological association between fibrous dysplasia and myxomas.
In this report, we describe the case of a 49-year-old Caucasian woman known for years to have fibrous dysplasia in the left femur and tibia who presented with progressive pain in her left leg and soft swelling in the left quadriceps region. After surgical intervention with excision of the soft-tissue mass, the diagnosis of Mazabraud's syndrome was confirmed. During follow-up, our patient presented with a painless mass located on the lateral side of the left knee, next to a second, intra-osseous lesion with the same characteristics in the left lateral tibial plateau. The histopathological examination was consistent with a soft-tissue intra-osseous myxoma.
In the international literature, 67 cases of Mazabraud's syndrome have been described so far.
To our knowledge, the present case report is the first to describe the combination of polyostotic fibrous dysplasia and intra-muscular as well as intra-osseous myxoma.
Mazabraud's syndrome is a rare but well-described disorder. It is characterized by fibrous dysplasia, which can develop in a single bone (monostotic) or in multiple bones (polyostotic), associated with one or more soft-tissue myxomas.
Fibrous dysplasia is a benign, intra-medullary, fibro-osseous lesion and usually develops in childhood or early adult life. In the 67 cases of Mazabraud's syndrome described so far, most patients had the polyostotic form of fibrous dysplasia.
Soft-tissue myxomas are benign mesenchymal tumors. In Mazabraud's syndrome, they usually occur (1) when the patient is at a more advanced age and (2) in close vicinity of the bones most severely affected by fibrous dysplasia.
We present the first case of a patient with Mazabraud's syndrome with an intra-osseous myxoma next to soft-tissue myxomas.
A 49-year-old Caucasian woman was referred to our center. She was known for years to have fibrous dysplasia in the left femur and tibia.
When she was 49 years old, an attempt was made to excise the fibrous dysplasia from the proximal femur. Extreme hemorrhaging complicated the operation. The attending orthopedic surgeon decided to refer the patient to our specialized center. At the time of her visit to our center, she complained about progressive pain in her left thigh and lower leg. Her clinical physical examination revealed soft swelling in the left quadriceps region.
Magnetic resonance imaging (MRI) of her left leg showed extensive fibrous dysplasia in the entire femur with expansive growth in the greater trochanter. The left proximal tibia also showed signs of fibrous dysplasia extending 20 cm distally from the tibial plateau. Four well-delineated, cyst-like, intra-muscular soft-tissue lesions were seen in the quadriceps region. Surgery was planned in two sessions. Prior to both operations, angiography and embolization of the pathologic vascularization in both the femur and the tibia were performed.
During the first operation, intra-lesional excision of the tumor of the left proximal femur was performed, followed by cryosurgery. A correctional osteotomy of the left hip was performed, followed by homologous bone transplantation and fixation with a proximal femoral nail. Because of a weakened femoral head, the femoral neck screw had to be stabilized with bone cement. Allograft bone chips were impacted to induce bone matrix. During the procedure, an incisional biopsy of the soft-tissue lesions in the quadriceps muscle was performed.
Three weeks later an intra-lesional excision of the fibrous dysplasia of the left tibia was performed, followed by cryosurgery and implantation of an massive allograft inlay in the tibia. The allograft was fixed with AO screws. During this procedure, the soft-tissue lesions in the quadriceps muscle were excised.
Post-operatively, the patient's treatment consisted of non-weight-bearing mobilization for three months in plaster of Paris. During follow-up, plain films were obtained at six-week intervals. Eventually, these images showed consolidation of the femur osteotomy and incorporation of the allograft.
During follow-up, MRI of the patient's left leg was performed at regular intervals. These scans showed no signs of recurrence in the first post-operative years.
Three years after her last operation multiple tumors in her left upper leg were felt, which raised clinical suspicions of myxomas. MRI scans showed five new soft-tissue lesions consistent with characteristics of myxoma in the upper and lower leg regions. All lesions were marked ultrasonographically and excised, followed by cryosurgery. Histopathological examination of all intra-muscular lesions confirmed the diagnoses. Post-operatively the patient recovered gradually. Every three months ultrasonography of her left leg was performed, which showed no signs of myxoma until 2009. By then, she had developed several new intra-muscular myxomas, which were not treated. At her last follow-up examination in early 2010, our patient was in good condition. Several myxomas had developed but were found to be stable on the basis of MRI.
Fibrous dysplasia in itself is not a rare disorder; it is reported to represent 5% to 7% of benign bone tumors . Monostotic presentation is more frequent, and the lesions are thought to occur as a result of a developmental failure in the remodeling of primitive bone to mature lamellar bone and a failure of the bone to realign in response to mechanical stress. These features result in substantial loss of mechanical strength, leading to pain, deformity, and pathological fractures . The etiology of fibrous dysplasia has been linked to a mutation in the Gsα gene, leading to an increase in cyclic adenosine monophosphate, which leads to so-called downstream effects important in the pathogenesis of fibrous dysplasia .
An intra-muscular myxoma is usually a solitary lesion that is not generally associated with any other clinically apparent abnormalities . It is a rare, benign mesenchymal tumor that is hypovascular, never exhibits an epithelial component, and probably never recurs locally .
Multiple intra-muscular myxomas are rare and usually are associated with fibrous dysplasia, a condition known as Mazabraud's syndrome. In Mazabraud's syndrome, the polyostotic form of fibrous dysplasia is present in the vast majority of patients. In general, the onset of fibrous dysplasia antedates the appearance of intra-muscular myxomas, and the soft-tissue lesions become apparent many years later, usually in the fifth or sixth decade of life . The sites affected are predominantly the large muscles of the thigh, shoulder, buttocks, and upper arm. To our knowledge, no Mazabraud's syndrome case associated with an intra-osseous myxoma has been reported to date.
There are different hypotheses for the association between fibrous dysplasia and intra-muscular myxomas. Some authors have suggested a basic metabolic error in both tissues during the initial growth period . Various authors have demonstrated that GNAS1 mutations exist in intra-muscular myxomas, which may play an important role in tumorigenesis in intra-muscular myxomas as well as in fibrous dysplasia .
The radiological diagnosis of fibrous dysplasia is generally established by plain films. Being larger, polyostotic lesions are more commonly accompanied by deformation, including coxa vara, the shepherd's crook deformity, bowing of the tibia, and protrusion acetabuli .
Ultrasound and MRI can be helpful to detect soft-tissue lesions in patients with Mazabraud's syndrome [9, 10]. Both imaging modalities show circumscript, fluid-like lesions with a cystic or multi-cystic appearance. Therefore, recognition of Mazabraud's syndrome with its known association of fibrous dysplasia and benign soft-tissue myxomas is of utmost importance to establish the final radiology-based diagnosis. However, histopathological confirmation is always mandatory.
Histopathologically, the characteristics of fibrous dysplasia and intra-muscular myxoma are as described in this case report. Both lesions are completely benign, and malignant transformation in fibrous dysplasia is uncommon.
In many cases, treatment of fibrous dysplasia is not necessary, since the lesions are discovered incidentally on plain radiographs and are asymptomatic. Clinical observation through follow-up radiographs is warranted to verify that there is no progression.
Different studies have reported clinical improvement in patients with fibrous dysplasia after bisphosphonate therapy [11–13], although there is no histological evidence of abnormal osteoclastic activity in fibrous dysplasia of bone.
Surgical treatment of fibrous dysplasia may be necessary to correct a deformity, to prevent a pathological fracture, and/or to relieve pain in symptomatic lesions. Upper-extremity lesions can often be treated conservatively, but surgical intervention is required for many comparable lower-extremity lesions. Other factors influencing the type of intervention used are the size and biological behavior of the lesion and the patient's age.
The use of curettage only (with or without autogenous cancellous bone grafting) is associated with a high risk of recurrence, since the cavity or graft of normal bone is replaced gradually by dysplastic bone in the healing process, returning the patient to the pre-operative state. Cortical allografts last longer, since these grafts show far less and slower internal replacement by host bone and are therefore preferable for reconstruction.
The treatment of intra-muscular myxomas is dependent on the extent of the lesions, and these lesions should be excised if pain or pressure symptoms develop [10, 14]. Our limited experience in using cryosurgery in soft-tissue tumors such as myxoma has shown that cryosurgery could be a powerful tool for the eradication of these tumors .
Mazabraud's syndrome is a rare disorder; hence the small number of publications in the literature since it was first described by Mazabraud in 1967.
According to a recent article, there have been only 67 reported cases to date . Our present report will probably be the 68th case, but it is the first report describing the combination of polyostotic fibrous dysplasia with intra-muscular and intra-osseous myxoma.
Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
- Henschen F: Fall von ostitis fibrosa mit multipelen tumoren in den umgebenden muskulatur. Verh Dtsch Ges Pathol. 1926, 21: 93-97.Google Scholar
- Mazabraud A, Semat P, Roze R: Apropos of the association of fibromyxomas of the soft tissues with fibrous dysplasia of the bones in French. Presse Med. 1967, 75: 2223-2228.PubMedGoogle Scholar
- Campanacci M: Bone and Soft Tissue Tumors: Clinical Features, Imaging, Pathology and Treatment. 1999, New York: Springer, 2View ArticleGoogle Scholar
- DiCaprio MR, Enneking WF: Fibrous dysplasia: pathophysiology, evaluation, and treatment. J Bone Joint Surg Am. 2005, 87: 1848-1864. 10.2106/JBJS.D.02942.View ArticlePubMedGoogle Scholar
- Marie PJ, de Pollak C, Chanson P, Lomri A: Increased proliferation of osteoblastic cells expressing the activating Gsα mutation in monostotic and polyostotic fibrous dysplasia. Am J Pathol. 1997, 150: 1059-1069.PubMedPubMed CentralGoogle Scholar
- Allen PW: Myxoma is not a single entity: a review of the concept of myxoma. Ann Diagn Pathol. 2000, 4: 99-123. 10.1016/S1092-9134(00)90019-4.View ArticlePubMedGoogle Scholar
- Wirth WA, Leavitt D, Enzinger FM: Multiple intramuscular myxomas: another extraskeletal manifestation of fibrous dysplasia. Cancer. 1971, 27: 1167-1173. 10.1002/1097-0142(197105)27:5<1167::AID-CNCR2820270523>3.0.CO;2-Z.View ArticlePubMedGoogle Scholar
- Okamoto S, Hisaoka M, Ushijima M, Nakahara S, Toyoshima S, Hashimoto H: Activating Gsα mutation in intramuscular myxomas with and without fibrous dysplasia of bone. Virchows Arch. 2000, 437: 133-137. 10.1007/s004280000217.View ArticlePubMedGoogle Scholar
- Iwasko N, Steinbach LS, Disler D, Pathria M, Hottya GA, Kattapuram S, Varma DG, Kumar R: Imaging findings in Mazabraud's syndrome: seven new cases. Skeletal Radiol. 2002, 31: 81-87. 10.1007/s00256-001-0453-0.View ArticlePubMedGoogle Scholar
- Kransdorf MJ, Murphey MD: Diagnosis please. Case 12: Mazabraud syndrome. Radiology. 1999, 212: 129-132.View ArticlePubMedGoogle Scholar
- Chapurlat RD, Delmas PD, Liens D, Meunier PJ: Long-term effects of intravenous pamidronate in fibrous dysplasia of bone. J Bone Miner Res. 1997, 12: 1746-1752. 10.1359/jbmr.19220.127.116.116.View ArticlePubMedGoogle Scholar
- Lane JM, Khan SN, O'Connor WJ, Nydick M, Hommen JP, Schneider R, Tomin E, Brand J, Curtin J: Bisphosphonate therapy in fibrous dysplasia. Clin Orthop Relat Res. 2001, 382: 6-12.View ArticlePubMedGoogle Scholar
- Liens D, Delmas PD, Meunier PJ: Long-term effects of intravenous pamidronate in fibrous dysplasia of bone. Lancet. 1994, 343: 953-954. 10.1016/S0140-6736(94)90069-8.View ArticlePubMedGoogle Scholar
- Silver WP, Harrelson JM, Scully SP: Intramuscular myxoma: a clinicopathologic study of 17 patients. Clin Orthop Relat Res. 2002, 403: 191-197.View ArticlePubMedGoogle Scholar
- Veth R, Schreuder B, van Beem H, Pruszczynski M, de Rooy J: Cryosurgery in aggressive, benign, and low-grade malignant bone tumours. Lancet Oncol. 2005, 6: 25-34.View ArticlePubMedGoogle Scholar
- Zoccali C, Teori G, Prencipe U, Erba F: Mazabraud's syndrome: a new case and review of the literature. Int Orthop. 2009, 33: 605-610. 10.1007/s00264-007-0483-x.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.